Pharma · Public company · Foster City, CA, US

Gilead Sciences, Inc.

Ticker GILD · SEC CIK 0000882095

Track this companyFree. Adds Gilead Sciences, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials2525 recruiting or active

Pipeline programs55From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline55

Amrubicin (Japan only)Phase 3 · Extensive Stage Small Cell Lung Cancer (ES-SCLC)ClinicalTrials.gov · fetched Nov 12, 2026
B/F/TAFPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
BIC/LEN FDCPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
BictegravirPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
Bictegravir/Lenacapavir (BIC/LEN) FDCPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
CapecitabinePhase 3 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
DoxorubicinPhase 3 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
F/TDFPhase 3 · Pre-Exposure Prophylaxis of HIV InfectionClinicalTrials.gov · fetched Nov 12, 2026
GS-3242 InjectionPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
GS-3242 TabletPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
LenacapavirPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
Lenacapavir InjectionPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
Lenacapavir TabletPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
Lurbinectedin (regions/countries where approved and available)Phase 3 · Extensive Stage Small Cell Lung Cancer (ES-SCLC)ClinicalTrials.gov · fetched Nov 12, 2026
Oral Lenacapavir (LEN)Phase 3 · Pre-Exposure Prophylaxis of HIV InfectionClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 3 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 3 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
PTM F/TDFPhase 3 · Pre-Exposure Prophylaxis of HIV InfectionClinicalTrials.gov · fetched Nov 12, 2026
PTM Oral LENPhase 3 · Pre-Exposure Prophylaxis of HIV InfectionClinicalTrials.gov · fetched Nov 12, 2026
Sacituzumab Govitecan (SG)Phase 3 · Extensive Stage Small Cell Lung Cancer (ES-SCLC)ClinicalTrials.gov · fetched Nov 12, 2026
Sacituzumab govitecan-hziyPhase 3 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
Sacituzumab govitecan-hziy (SG)Phase 3 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
SeladelparPhase 3 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
Stable Baseline RegimenPhase 3 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
Sub-cutaneous (SC) Lenacapavir (LEN)Phase 3 · Pre-Exposure Prophylaxis of HIV InfectionClinicalTrials.gov · fetched Nov 12, 2026
TopotecanPhase 3 · Extensive Stage Small Cell Lung Cancer (ES-SCLC)ClinicalTrials.gov · fetched Nov 12, 2026
BevacizumabPhase 2 · Advanced Microsatellite Stable Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
BevacizumabPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Cilofexor Dose APhase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
Cilofexor Dose BPhase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
DenikitugPhase 2 · HER2-negativeClinicalTrials.gov · fetched Nov 12, 2026
DenikitugPhase 2 · Advanced Microsatellite Stable Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
GS-3242Phase 2 · HIV-1 InfectionClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 2 · HER2-negativeClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 2 · Advanced Microsatellite Stable Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 2 · HER2-negativeClinicalTrials.gov · fetched Nov 12, 2026
PTM Cilofexor Dose APhase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
PTM Cilofexor Dose BPhase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
PTM SeladelparPhase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
RamucirumabPhase 2 · HER2-negativeClinicalTrials.gov · fetched Nov 12, 2026
Trifluridine-TipiracilPhase 2 · Advanced Microsatellite Stable Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
TUB-040Phase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
GS-1206Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
GS-2426Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
GS-4571Phase 1 · Weight ManagementClinicalTrials.gov · fetched Nov 12, 2026
GS-5319Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
OmeprazolePhase 1 · Weight ManagementClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Cabotegravir (CAB)HIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Emtricitabine/tenofovir alafenamide (F/TAF)HIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Emtricitabine/tenofovir disoproxil fumarate (F/TDF)HIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Lenacapavir InjectionHIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Lenacapavir TabletHIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

HIV/HBV/HCV Triple Screening in Primary CareNA · RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07031219 · fetched Nov 12, 2026
Substudy-01: A Study of Long-Acting HIV-1 Treatments Taken by Mouth in People With HIV-1 With Undetectable Virus LevelsPHASE2 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07841990 · fetched Nov 12, 2026
Study of Seladelpar and Cilofexor in Participants With Primary Biliary CholangitisPHASE2 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07841977 · fetched Nov 12, 2026
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal AdenocarcinomasPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 7, 2026ClinicalTrials.gov NCT07546812 · fetched Nov 12, 2026
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 TreatmentPHASE2_PHASE3 · RECRUITING · started Jul 29, 2026ClinicalTrials.gov NCT07708727 · fetched Nov 12, 2026
A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid TumorsPHASE1 · RECRUITING · started Jul 17, 2026ClinicalTrials.gov NCT07703878 · fetched Nov 12, 2026
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1PHASE2 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07645287 · fetched Nov 12, 2026
Study of GS-2426 in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Jun 2, 2026ClinicalTrials.gov NCT07601243 · fetched Nov 12, 2026
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal CancerPHASE2 · RECRUITING · started May 19, 2026ClinicalTrials.gov NCT07527858 · fetched Nov 12, 2026
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV PreventionRECRUITING · started Mar 17, 2026ClinicalTrials.gov NCT07473778 · fetched Nov 12, 2026
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEPPHASE4 · RECRUITING · started Jan 13, 2026ClinicalTrials.gov NCT07218211 · fetched Nov 12, 2026
Prospective Registry of ADC as First- and Second-line Treatment for Breast CancerRECRUITING · started Oct 8, 2025ClinicalTrials.gov NCT06774027 · fetched Nov 12, 2026
Study of GS-5319 Given Alone or in Combination in Adults With Solid TumorsPHASE1 · RECRUITING · started Aug 28, 2025ClinicalTrials.gov NCT07128303 · fetched Nov 12, 2026
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung CancerPHASE3 · RECRUITING · started Apr 4, 2025ClinicalTrials.gov NCT06801834 · fetched Nov 12, 2026
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)PHASE1 · RECRUITING · started Aug 28, 2024ClinicalTrials.gov NCT06562907 · fetched Nov 12, 2026
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)PHASE3 · ACTIVE_NOT_RECRUITING · started Aug 28, 2024ClinicalTrials.gov NCT06486441 · fetched Nov 12, 2026
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLCPHASE1_PHASE2 · RECRUITING · started Jun 12, 2024ClinicalTrials.gov NCT06303505 · fetched Nov 12, 2026
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With BiktarvyPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 25, 2024ClinicalTrials.gov NCT06333808 · fetched Nov 12, 2026
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated CirrhosisPHASE3 · RECRUITING · started Sep 7, 2023ClinicalTrials.gov NCT06051617 · fetched Nov 12, 2026
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland CancersPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 27, 2023ClinicalTrials.gov NCT05884320 · fetched Nov 12, 2026
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)PHASE3 · RECRUITING · started Dec 12, 2022ClinicalTrials.gov NCT05633654 · fetched Nov 12, 2026
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1)PHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Aug 16, 2022ClinicalTrials.gov NCT05502341 · fetched Nov 12, 2026
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During PregnancyPHASE4 · ACTIVE_NOT_RECRUITING · started Apr 4, 2022ClinicalTrials.gov NCT05140941 · fetched Nov 12, 2026
Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV InfectionPHASE3 · ACTIVE_NOT_RECRUITING · started Jun 28, 2021ClinicalTrials.gov NCT04925752 · fetched Nov 12, 2026
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPHASE1_PHASE2 · RECRUITING · started Mar 30, 2018ClinicalTrials.gov NCT03424005 · fetched Nov 12, 2026

SEC filings12

10-Q · FORM 10-QSEC EDGAR · filed Oct 30, 2026 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
10-Q · FORM 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed Aug 4, 2026 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed May 20, 2026 · fetched Nov 12, 2026
10-Q · FORM 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed Apr 28, 2026 · fetched Nov 12, 2026
10-K · FORM 10-KSEC EDGAR · filed Feb 24, 2026 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed Feb 23, 2026 · fetched Nov 12, 2026
8-K · FORM 8-KSEC EDGAR · filed Feb 10, 2026 · fetched Nov 12, 2026